Eagerly awaiting the IPO of Origin Therapeutics ($ORIG $ORIG.c) on the CSE, an investment issuer focused on making equity investments in psychedelic-related companies.
The psychedelic space is a $100B market opportunity and $ORIG provides investors with diverse exposure into the sector by investing in both public and private companies.
Investment highlights:
$KETA is a technology company operating a virtual clinic and telehealth platform that connects patients to licensed physicians in the US for a prescribed treatment program of low-dose, oral ketamine medication.
On the forefront of two major emerging trends, psychedelic medicine and telehealth, $KETA has seen solid growth in the past year and its public listing will continue to fuel its trajectory with increased investor participation and awareness.
$KETA's success is a "demonstration of $ORIG's active management approach and how it can help to provide investors with upside potential when compared to passive investments in the sector" says $ORIG CEO Alexander Somjen.
$ORIG is looking like a solid investment IMO, I'm thinking their IPO will be a hit once they are approved to list.
https://originpsychedelics.com/news...-trading-on-the-canadian-securities-exchange/
Check out this in-depth DD packet on $ORIG:
The psychedelic space is a $100B market opportunity and $ORIG provides investors with diverse exposure into the sector by investing in both public and private companies.
Investment highlights:
- Early access to privately held companies
- Diversified portfolio of companies to maximize exposure while managing risk
- Powerhouse team with expertise in growing companies
- Emerging industry with high growth trajectory
$KETA is a technology company operating a virtual clinic and telehealth platform that connects patients to licensed physicians in the US for a prescribed treatment program of low-dose, oral ketamine medication.
On the forefront of two major emerging trends, psychedelic medicine and telehealth, $KETA has seen solid growth in the past year and its public listing will continue to fuel its trajectory with increased investor participation and awareness.
$KETA's success is a "demonstration of $ORIG's active management approach and how it can help to provide investors with upside potential when compared to passive investments in the sector" says $ORIG CEO Alexander Somjen.
$ORIG is looking like a solid investment IMO, I'm thinking their IPO will be a hit once they are approved to list.
https://originpsychedelics.com/news...-trading-on-the-canadian-securities-exchange/
Check out this in-depth DD packet on $ORIG: